Earnings Report Digest

$DIS has released its Q4 earnings report, reflecting solid momentum as the company navigates through recent challenges. Highlights include increased revenues, improved profitability, and strong subscriber growth in streaming 📈. Key stats show a healthy adjustment EPS growth forecast of high single digits for 2025, rising to double digits in subsequent years, indicating a focus on long-term growth 📊. Risks involve economic conditions and competition. The future appears promising with new content launches and integrated streaming strategies 🌟. Check details in valueverge.com/DIS.

Trending stocks, Feb 5, 2025

$GOOG has released its Q4 2024 earnings report, showing a mixed performance. Key highlights include EPS of $2.15, beating expectations, and a revenue of $96.47B, which slightly missed forecasts by $199.97M.

$TDG has released its Q1 2025 earnings report showcasing an EPS of $7.83, beating expectations but revenue of $2.01B missed by $20.53M. Key risks involve ongoing challenges in the commercial OEM space due to Boeing's production delays. Financial health appears robust with a 52.9% EBITDA margin and strong cash flow of over $750M.

$MDLZ has released its Q4 earnings, reporting an EPS of $0.69, surpassing estimates by $0.04, but revenue fell short by $51.52M at $9.60B, reflecting 3.11% growth year-over-year.

$CMG reports quarterly earnings with an EPS of $0.25, matching expectations, but revenue slightly missed at $2.85B, up 13% YoY. Sales growth was driven by digital sales, constituting 34% of totals. Risks include increased food costs amid inflation and competitive pricing pressures, impacting margins which fell to 24.8%. Future growth looks positive, but comps face tough comparisons in Q1 2025. Opportunities stem from innovative equipment and international expansion. More details at http://valueverge.com/CMG.

$PFE announces its Q4 2024 earnings, reporting EPS of $0.63, beating estimates by $0.17, and revenue of $17.76B, a remarkable 24.66% YoY growth, exceeding expectations.

$AMGN has released its Q4 2024 earnings, featuring an EPS of $5.31, surpassing expectations by $0.23, and revenues of $9.09B, up 10.86% YoY. The company recorded robust product sales growth of 19% for the full year and sustained momentum across key medications like Repatha and EVENITY, with significant unmet patient needs driving future potential.

$AMD has released its Q4 2024 earnings, reporting EPS of $1.09 and revenue of $7.66B, reflecting a 24% y/y growth. The data center and client segments continue to shine, with data center revenue up 69%. However, gaming revenue is down 59%, posing a risk to future growth.

$MPLX reports solid Q4 2024 earnings, with adjusted EBITDA up 9% year-over-year to $1.8 billion, and a 12.5% distribution increase for unitholders. Key highlights include mid-single digit adjusted EBITDA growth continued into 2024, backed by $6.8 billion full-year adjusted EBITDA and strong performance in their Natural Gas and NGL Services.